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Abstract
Mathematical models are finding increased use in biology, and partuculary in the
field of cancer research. In relation to cancer, systems of differential equations have
been proven to model tumor growth for many types of cancer while taking into
account one or many features of tumor growth. One feature of tumor growth that
models must take into account is that tumors do not grow exponentially. One model
that embodies this feature is the Gomperts Model of Cell Growth. By fitting this
model to longterm breast cancer study data, this project ascertains gompertzian
parameters that can be used to predicts tumor growth as a function of time.
Contents
Abstract 1
Dedication 5
Acknowledgments 6
1 Introduction 7
2 An Introduction to Cancer 9
2.1 Cancer . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 9
2.2 Tumor Biology . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 10
3 Mathematical Models 11
3.1 Overview . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 11
3.2 Bloom Data . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 12
3.3 The Gompertz Model of Cell Growth . . . . . . . . . . . . . . . . . . 12
3.4 Norton’s Fit . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 14
3.5 Norton’s Parameters . . . . . . . . . . . . . . . . . . . . . . . . . . . 15
4 Project Fit 16
4.1 Poject Model . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 16
4.2 lsqcurvefit . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 16
5 Conclusion 18
5.1 Conclusion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 18
Contents 3
A Matlab Code 19
A.1 Gompertz Mode . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 19
A.2 Code to Fit Gompertz Model to Study Data . . . . . . . . . . . . . . 19
List of Figures
2.1.1 Structure of a Tumor Spheroid . . . . . . . . . . . . . . . . . . . . . . 10
3.2.1 Bloom Data (Reproduced from [22]). . . . . . . . . . . . . . . . . . . 13
3.2.2 Graphical Representation of Bloom Data. . . . . . . . . . . . . . . . . 13
4.2.1 A Gompertzian Fit to the Bloom Data. . . . . . . . . . . . . . . . . . 17
Dedication
I dedicate this project to the prisoners in New York State who could accomplish
similar work if only provided an educational opportunity comparable to the one
Bard College has granted me.
Acknowledgments
I must thank, first and foremost, my adviser Dr. Micheal Tibbetts for his guidance
and constant encouragement throughout this process. His believed that I would finish
despite my own doubt and uncertainty. Further, thank you to Professors Keri-Ann
Norton and Stefan Mendez-Diez for their work advising on this project. Thank you
to Max Kenner, the Bard Prison Initiative, and Bard College for having created
the opportunity for me to be a Bard student. Thank you to my family for having
supported me throughout my imprisonment, and having granted me the peace of
mind to focus on my studies under adverse circumstances. Thank you to Lynn
Novick and Sarah Botstein for their encoragement and support as well as for the
BPI documentary they have under production. Your film shall change the world.
1
Introduction
At the intersection of mathematics and biology resounds a call to use math in
this century to do what it did for physics in the twentieth-century [1]. That is,
to apply math to biology in such a manner as to increase the predictive power of
the biological field [1]. Let us recall that Physicists mathematically predicted the
Higgs Bosun before having materially discovered it. Such predictive power can be
harnessed toward biology to aid in areas of cancer research, bioinformatics, and
drug testing, to name a few. In the arena of cancer research, mathematical models
have become more and more common as a means to model cancer cell proliferation,
drug scheduling, and tumor development. Researchers have erected many different
models for cancer cell proliferation, ranging form those that model with one degree
of freedom, say tumor size, to those that model cancer at several degrees of freedom,
say growth, necrosis, and angiogenesis [10]. One of the problems that has arisen with
modeling tumor growth is that tumors do not grow exponentially. In other words,
tumor cell proliferation cannot be reduced to the biology of cell divison, mitosis.
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This problem means that, even at one degree of freedom, tumor growth has to be
modeled with mathematically nuanced constructs.
Models constructed with differential eaquations have been proven to accurately
predict tumor growth curves for many types of tumor [10]. One differential equation
model tha manages such predictions with a high degree of fidelity is the Gompertz
Model of cell growth. The Gompertz Model’s key feature is that it accounts for ex-
ponientail decay. In relation to tumor growth, this feature means that the Gompertz
Model captures how tumour growth rates decrease as a the mass of the tumour in-
creases. This project fits the Gompertz Model to a dataset prudeced by Bloom et.
al. that tracked untreated breast cancer in 250 over about twenty years. By fitting
the model to this datatset, this project can ascertain gompertzian pararmeters to
predict breast tumor growth rates as a fuction of time.
2
An Introduction to Cancer
2.1 Cancer
Cancer constitutes a highly dynamic set of diseases grounded in genomic mutations
that cause malignant cellular growth [2]. In a classic review article titled ”The
Hallmarks of Cancer,” Hanahan and Weinberg compile the traits that make a disease
a cancer [2]. They identify six physiological characteristics of cell biology that
converge to cause malignant growth: self-sufficiency in growth signals, insensitivity
to growth-inhibitory signals, evasion of apoptosis, limitless replicative potential,
sustained angiogenesis, and tissue invasion coupled with metastasis [2]. As a tumor
develops, it must acquire each of these physiologic changes in order to breach cellular
anticancer mechanisms [2]. It is thus helpful to view cancer as the outcome of a
multistep process wherein the disease emerges from an interplay of factors resulting
from progressive genomic alterations [2]. Hanahan and Weinberg’s traits, undergird
the interplay of factors that cause cancer, and the vast majority, if not all, human
cancers share those six traits [2].
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Figure 2.1.1. Structure of a Tumor Spheroid
2.2 Tumor Biology
Cancer manifests in the form of a tumor spheroid, an abnormal mass of uncontrol-
lably dividing cells. A tumor spheroid generally develops three cell regions, as seen
in Figure 1.1.1, that differ in accordance with nutrient supply. The cells in the pro-
liferative zone, P, undergo constant cell division as they have access to the nutrients
necessary for proliferation [2]. The quiescent layer of cells, Q, lose their ability to
proliferate due to an insufficient nutrient supply, but receive enough sustenance to
remain alive. The cells that constitute the necrotic core, N, however, die due to
prolonged nutrient deficiency. As a tumor spheroid grows, it becomes harder for the
cells toward its centre and core to receive nutrients.
3
Mathematical Models
3.1 Overview
Over the past several decades, the factors and forces that drive tumor growth—
tumor growth kinetics—have come under biological study, and, hence, have garnered
extensive experimental study [10]. Researchers have found that both human and an-
imal relative tumor growth rates diminish with time [10]. Or, to restate this finding,
the time it takes for human and animal tumors to double in size increases with time
[10]. Such characteristics, the differential relation of tumor growth rates to time,
make tumorigenesis favorable to expression in the form of differential equations.
A differential equation constitutes a mathematical formalism relating a function
to its derivatives. It is a relational concept in the form of an equation. The func-
tion usually represents a quantifiable physical entity while its derivatives describe
that quantities which that entity changes with time, its rate of change [18]. When
related with an equation, of tumors many mathematical constructs have been devel-
oped to model tumorigenesis. At the most basic, such constructs model cancer-cell
proliferation. The more complicated constructs model cancer-cell proliferation in
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conjunction with with factors such as, necrosis, angiogenesis, and tumor response
to drug treatment.
Mathematical modeling provides for the expression of which effects one wants
to consider to the exclusion of those one may not understand or find of interest
[18]. This degree of flexibility has great value to the study of cancer in two ways,
1) models can provide a vehicle to test theoretical hypotheses of tumor growth by
assessing a theories descriptive power against experimental data, and 2) models can
estimate the pattern on tumor development for use as a prognostic clinical tool or
to assess the clinical efficacy of drug therapies under development [10].
3.2 Bloom Data
One of the datasets Norton applies the Gompertz model to is that of Bloom et.
al. from their article, ”Natural History of Untreated Breast Cancer (1805-1933)
Comparison of Untreated and Treated Cases According to Histological Grade Ma-
lignancy”. At Middlesex Hospital, London, Bloom et. al. tracked 250 untreated cases
of breast cancer in woman. The study occurred during the period 1803-1820 from
the patients onset of symptoms through death [22]. Figure 3.2.1 constitutes a re-
production of the Bloom study data. As seen in Figure 3.2.1, all the patients in the
study had died with twenty years [22].
Graphing the data in Figure 3.2.1. produces the curve seen in Figure 3.2.2.
3.3 The Gompertz Model of Cell Growth
As discussed in Section 1.2, a tumor will grow more slowly the bigger it becomes as
less and less of its cell mass will be concentrated within the proliferative zone relative
to the number of cells at the tumor’s centre and core. Mathematically speaking, this
decrease in the growth rate embodies means that tumor’s exhibit non-exponential
3. MATHEMATICAL MODELS 13
Deaths Occurring Each Year, Calculated from Onset of Symptoms for 250 
Untreated Cases of Breast Cancer 
Year of Death No. of Cases Cumulative Total Survivals 
1 34 34 216 86% 
2 52 86 164 66% 
3 55 141 109 43.6% 
4 38 179 71 28% 
5 25 204 46 18.4% 
6 13 217 33 13% 
7 10 227 23 9% 
8 6 233 17 7% 
9 5 238 12 5% 
10 3 241 9 3.6% 
11 4 245 5 2% 
13 1 246 4 1.6% 
15 2 248 2 0.8% 
16 1 249 1 0.4% 
19 1 250 0 0.0% 
Survival of Treated Breast Cancer, Middlesex Hospital, 1805-1933 (250 Cases). 
 
Figure 3.2.1. Bloom Data (Reproduced from [22]).
 
Figure 3.2.2. Graphical Representation of Bloom Data.
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growth patterns, which the Gompertz model takes into account. The Gompertz
model’s essential characteristic is its ability to exhibit exponential decay of relative
tumor growth rates (SB). In other words, the Gompertz model embodies the fact
that tumor cell growth rates decrease as a function of time.
The Gompertz equation had originally been constructed for the purpose of actuar-
ial analysis, but later came into use a a growth curve. In a 1984 paper,”A Stochastic
Numerical Model of Breast Cancer that Simulates Clinical Data”, Speer et. al. pro-
pose that every individual tumor initially grows with identical Gompertzian param-
eters, and then becomes kinetically heterogenous through a random time-dependent
process [4,20]. In his 1988 paper, ”A Gompertzian Model of Human Breast Cancer
Growth”, Larry Norton points out that neither theory nor data support Speer et.
.al.’s assumption of uniform nascent tumor growth, and, further, that the complex
growth curves produced by Speer et. al.’s model fail to fit individual cancer growth
patterns. Considering the clinical and theoretical importance of human breast can-
cer, and in response to Speer et. al., Norton fits a parsimonious, unadorned Gom-
pertzian Model to three historical datasets by taking kinetic heterogeneity as an
intrinsic property of neoplasia.
3.4 Norton’s Fit
Norton lays out the gompertzian equation as:
N(t) = N(0)ek[1−e
(−bt)] (3.4.1)
where k = log e
[
N(∞)
N(0)
]
.
N(t) is a function of N(0), t, and b as well as a limiting size N(∞). As the
Gompertz model has been adapted to the kinetics of tumor growth, Norton analyses
his data with N(t) as the size of an individual patient’s tumor at time t, which he
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measures from the onset of symptoms [4]. He defines tumor size at the onset of
symptoms as N(0) and holds N(∞) constant [4]. By rearrangement of of equation
3.4.1:
ti =
(−1
bi
log e1− 1
k
log−e
(
NL
N(0)
))
(3.4.2)
where Pt(ti) equals a portion of the 250 cancers from the Bloom data with Gom-
pertzian parameters b ≤ bi.
Using these methods, Norton Norton was ablw to define the probability distri-
bution of b ! [21, ?Ln]. He then randomly chose a value of bi from the normal-log
distribution and calculated ti for N(ti) = NL. Using Values of ti, he estimated PL(t),
which he graphically compared with PL(t) from the Bloom Data [4].
3.5 Norton’s Parameters
Norton finds that the Bloom data reflects the Gompertzian equation with N(0) =
4.8 × 109 cells, N(∞) = 3.1 × 1012 cells, and lethal tumor cell count of NL = 1012
cells ‘[4].
4
Project Fit
4.1 Poject Model
Equation 3.2.1 is an analytic solution to the following system of differential equations
[20]: {
dN
dt
= −rNln (N
K
)
;N(0) = N0
N(t = 0) = 1mm3
(4.1.1)
which we can solve exactly as
N(t) = K
(
N0
k
)e−rt
(4.1.2)
from which we can see that the volume asymptotically converges to a carrying given
by K = N0e
r0
r . r specfies growth in proportion to cell population size. The cell
population will only grow faster as it becomes larger if it is below the carrying
capacity.
4.2 lsqcurvefit
In Matlab, I fit the equation to the Bloom data using lsqcurvefit, which solves
nonlinear equations in the least-squares sense. More specifically, lsqcurvefit takes
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the given xdata, coupled with observed ydata, and finds coefficients best-fitted to
the equation
min
x
1
2
‖F (x, xdata)− ydata‖22 =
1
2
∑
i
(F (x, xdatai)− ydatai)2 (4.2.1)
where the xdata and ydata constitute vectors and F (x, data) constitutes a vector
valued function [18]. The Matlab code for using this equation with the Bloom data
is in Appendix A.2.
Fitting the Gompertz model to the Bloom data, using lsqcurve fit via the Matlab
code in Apendix A.1 , returns the following fit and parameters:
 
Figure 4.2.1. A Gompertzian Fit to the Bloom Data.
r = 8.032444124239194e− 09
K = 1.037246983488218e + 02 billion cells
N0 = 1.34 million cells.
5
Conclusion
5.1 Conclusion
This project demonstrates that the Gompertz Model of Cell Growth accurately
models tumor growth in accordance with Norton findings that an unadorned gom-
pertzian model is sufficient to predict tumor growth. Taking the Bloom data and
fitting it with the gompertzian model returned parameters r, K and,N0, consistent
with Norton et. al.’s findings.
Appendix A
Matlab Code
A.1 Gompertz Mode
functionV = Gompertz(p, t)
V = p(1). ∗ (p(2)/p(1)).exp(−p(3) ∗ t);
withparametersp(1) = K, p(2) = initialpopulation, andp(3) = r
End
A.2 Code to Fit Gompertz Model to Study Data
years = [0123456789101113151619];
percent = [100866643.62818.4139753.621.6.8.40];
p0 = [.11000];// options = optimset(′MaxFunEvals′, 100000,′Maxiter′, 5000);
[p, error] = lsqcurvefit(@gompertz, p0, years, percent, [], [], options)
modelpercent = gompertz(p, years);
plot(years, percent,′ o′, years,modelpercent)
Bibliography
[1] Bellomo, N. et. al. (2007). On The Foundations of Cancer Modelling: Selected Topics, Speculations, and
Perspectives. Mathematical Models and Methods in Applied Sciences. 18:4, 593-646.
[2] Weinberg, R.A. (2014). The Biology of Cancer, Second Edition. New York: Garland Science.
[3] Altrock, P.M. et. al. (2015). The Mathematics of Cancer: integrating quantitive models. Nature. 15, 730-745.
[4] Norton, L. (1988). A Gompertzian Model of Human Breast Cancer Growth. Cancer Research, 48, 7067-7071.
[5] Zhang, P. and Brusic, V. (2014). Mathematical Modeling for Novel Cancer Drug Discovery and Development.
Expert Opinion on Drug Discovery, 9:10, 1133-1150.
[6] Folkman, J. (2002). Role of Angiogenesis in Tumor Growth and Metastasis. Seminars in Biology, 29:6, 15-18.
[7] Baylin, S.B. and Ohm, J.E. (2006). Epigenetic Gene Silencing in Cancer–a mechanism for early oncogenic
pathway addiction. Nature Reviews, 6, 107-116.
[8] Vogelstein, B. and Kinzler, K.W. (2004). Cancer Genes and the Pathways they Control. Nature Medicine,
10:8, 789-799.
[9] Friedl, P. and Wolf, K. (2003). Tumour-Cell Invasion and Migration: Diversity and Escape Mechanisms. Nature
Reviews, 3, 362-374.
[10] Benzerky, S. et al. (2014). Classical Mathematical Models for the Description and Prediction of Experimental
Tumor Growth. PLOS Computational Biology, 10:8, e1003800.
[11] Engelhart, M. et al. (2010). Optimal Control for Selected Cancer Chemotherapy ODE Models: A View on the
Potential of Optimal Schedules and Choice of Objective Function. Mathematical Biosciences, 229, 123-134.
[12] Masood, S.A. et. al. (2006). Specific Killing of Multiple Myeloma Cells by (-)-epigallocatechin-3-gallate Ex-
tracted from Green Tea: Biologic Activity and Therapeutic Implications. Blood, 108:8, 2804-2810.
[13] Hanahan, D. and Weinberg, R.A. (2000). The Hallmarks of Cancer. Cell, 100, 57-70.
[14] Anderson, A.R.A .et. al. (2000). Mathematical Modelling of Tumour Invasion and Metastasis. Journal of
Theoretical Medicine, 2, 129-54.
[15] Byrne, H.M. and Chaplain, M.A.J. (1996). Modelling the Role of Cell-Cell Adhesion in the Growth and
Development of Carcinomas. Mathematical Computational Biology, 24:12, 1-17.
[16] Magni, P. et. al. (2006). A Mathematical Model to Study the Effects of Drugs Administration on Tumour
Growth Dynamics. Mathematical Biosciences 200, 127-157.
[17] Kirscher, D. and Panetta, J.C. (1998). Modeling Immunotherapy of the Tumor-Immune. Journal of Mathe-
matical Biology, 37, 235-252.
[18] Davis, P. (1999). Differential Equations: Modeling With Matlab. New Jersey: Prentice Hall.
BIBLIOGRAPHY 21
[19] Pelengaris, S. and Khan, M. (2013). Introduction. In S. Pelengaris and M. Khan (Eds.), The Molculear Biology
of Cancer: A Bridge from Bench to Bedside, Second Edition. West Sussex: Wiley-Blackwell.
[20] Speer, J.F. et. al. (1984). A Stochastic Numerical Model of Breast Cancer that Simulates Clinical Data. Cancer
Research, 44, 4124-4130.
[21] Norton, L. et. al. (1976). Predicting the Course of Gompertzian Growth. Nature, 264, 542-545.
[22] Bloom, H.J.G. (1962). Natural History of Untreated Breast Cancer (1805-1933) Comparison of Untreated and
Treated Cases According to Histological Grade of Malignancy. British Medical Journal, 2, 5299, 213-222.
